Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WHY MMP licenses are treated as a NON material event

the important issues, and that explains why you have been so wrong with your knowledge and expectations and for so long.

I'm sorry you feel I don't add nothing new to the board, but your desire to censor me doesn't matter much.

The clock is ticking on your investment, and that means not just on Patent infringment recovery, but just as importantly, on your (and my) ability to sell our shares to others who will be gauging the financial prospects and limits of Infringment recovery remaining before they'll do you a favor and buy this stock from you at anywhere near what you and those shortsided posters think the price will rise to. It's not a lost cause, it CAN happen, but changes to the status quo HAVE to happen first.

Licenses alone do not equal a high PTSC stock price, that is another complex reality you appear unwilling to fully appreciate. TPL and Alliasence will make money regardless if PTSC stock does well or not.

I think PTSC investors better stop sitting back supporting the same old party line if they want to see this company and it's stock succeed. Because my friend, in many ways, this is the second half of the 4th and final quarter.

Share
New Message
Please login to post a reply